Director Vuk Jeremic gets 50,000 Aureus Greenway (AGH) shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Jeremic Vuk reported acquisition or exercise transactions in this Form 4 filing.
Aureus Greenway Holdings Inc director Vuk Jeremic received a grant of 50,000 shares of Common Stock on January 29, 2026. The shares were awarded at $0.001 per share as a non-derivative grant, bringing his directly owned holdings to 50,000 shares after the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Jeremic Vuk
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 50,000 | $0.001 | $50.00 |
Holdings After Transaction:
Common Stock — 50,000 shares (Direct, null)
Footnotes (1)
Key Figures
Shares granted: 50,000 shares
Grant price per share: $0.001 per share
Shares owned after transaction: 50,000 shares
+1 more
4 metrics
Shares granted
50,000 shares
Common Stock grant on January 29, 2026
Grant price per share
$0.001 per share
Non-derivative Common Stock award
Shares owned after transaction
50,000 shares
Total non-derivative holdings after grant
Acquisition transactions
1 transaction
Form 4 transactionSummary acquireCount
Key Terms
Common Stock, Grant, award, or other acquisition, non-derivative, Form 4
4 terms
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
non-derivative financial
"transaction_type: "non-derivative""
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did Aureus Greenway Holdings (AGH) report for Vuk Jeremic?
Aureus Greenway Holdings reported that director Vuk Jeremic received a grant of 50,000 shares of Common Stock. The Form 4 classifies this as a non-derivative grant, award, or other acquisition rather than an open-market purchase or sale.
What are Vuk Jeremic’s Aureus Greenway (AGH) holdings after this Form 4 transaction?
Following the reported grant, Vuk Jeremic directly owns 50,000 shares of Aureus Greenway Common Stock. The Form 4 lists these 50,000 shares as his total non-derivative holdings after the transaction, with ownership type marked as direct.
Was the Aureus Greenway (AGH) Form 4 transaction an open-market buy or sell?
No, the transaction was not an open-market buy or sell. The Form 4 uses code “A” and describes it as a “Grant, award, or other acquisition,” indicating compensation-related share issuance rather than market trading activity.
Does the Aureus Greenway (AGH) Form 4 show any derivative securities for Vuk Jeremic?
The filing shows no derivative transactions or positions for Vuk Jeremic. The derivativeSummary section is empty, and all reported activity relates only to non-derivative Common Stock granted on January 29, 2026.